No Data
IRTC iRhythm Technologies
Watchlist- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About iRhythm Technologies Company
iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.
Revenue Breakdown
News
Derrick Sung Joins Aerin Medical as Chief Financial Officer
Is IRhythm Technologies, Inc. (NASDAQ:IRTC) Trading At A 44% Discount?
Key Insights The projected fair value for iRhythm Technologies is US$147 based on 2 Stage Free Cash Flow to Equity iRhythm Technologies' US$81.60 share price signals that it might be 44% undervalued
New Research Presented at American Heart Association's 2023 Scientific Sessions Demonstrates Performance of Continuous Monitoring ECG Data for Improved Prediction of Heart Failure Hospitalization
SAN FRANCISCO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the results of a new retrospective analysis, conducted in partnership with Duke Health, that found incorporating
Comments

1. Circle: $3.3 billion
2. Bill․com: $670 million
3. Roku: $487 million
4. BlockFi: $227 million
5. Roblox: $150 million
6. Sunrun: $80 million
7. Ginkgo Bio: $74 million
8. iRhythm: $55 million
9. Rocket Lab: $38 million
10. Sangamo Thera: $34 million
11. Lending Club: $21 million
12. Huuuge Inc: $24 million
13. Payoneer: $20 million
14. Ambarella: $17 million
15. Protagonist Thera: $13 million
16. Oncorus: $10 million
17. Eig...
ColumnsToday's pre-market stock movers: WMT, AMZN, KO, BABA and more
In reaction to earnings/guidance:
$Liberty Energy(LBRT.US$ +11.6%, $F5 Inc(FFIV.US$ +6.9%, $Encore Wire(WIRE.US$ + 5.6%, $Archer Daniels Midland(ADM.US$ +5.5%, $Bank of N.T Butterfield & Son(NTB.US$ +5%, $Albany International(AIN.US$ +5%, $3M(MMM.US$ +4.0%,
Other news:
$Shell Midstream(SHLX.US$ +10% (Shell USA to acquire all units in SHLX held by public at $15.85/unit total value $1.96 bln)
$BridgeBio Pharma(BBIO.US$...